secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0001213900-24-035893
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech amends forward purchase agreement, sets floor price at $1.2743 and allows 248,360 additional shares
--------------------------------------------------------------------------------

- Second amendment to OTC equity prepaid forward transaction with Sandia Investment Management LP dated April 18, 2024.
- Reset price floor set at $1.2743; weekly adjustment formula revised to 90% of prior week VWAP but not below floor.
- Seller may deliver notice for up to 248,360 additional shares under the confirmation, subject to applicable share limit.
- NKGen acknowledges non-public information possession; Seller waives claims related to material non-public information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024035893/0001213900-24-035893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024035893/ea0204576-8k_nkgenbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-035893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer